<?xml version="1.0" encoding="UTF-8"?><rss version="2.0"
	xmlns:content="http://purl.org/rss/1.0/modules/content/"
	xmlns:wfw="http://wellformedweb.org/CommentAPI/"
	xmlns:dc="http://purl.org/dc/elements/1.1/"
	xmlns:atom="http://www.w3.org/2005/Atom"
	xmlns:sy="http://purl.org/rss/1.0/modules/syndication/"
	xmlns:slash="http://purl.org/rss/1.0/modules/slash/"
	>

<channel>
	<title>度拉糖肽售价 &#8211; 元哲咨询</title>
	<atom:link href="https://www.yuanzhezixun.com/tag/dulatangtaishoujia/feed/" rel="self" type="application/rss+xml" />
	<link>https://www.yuanzhezixun.com</link>
	<description>行业研究专家</description>
	<lastBuildDate>Mon, 17 Jul 2023 05:14:54 +0000</lastBuildDate>
	<language>zh-Hans</language>
	<sy:updatePeriod>
	hourly	</sy:updatePeriod>
	<sy:updateFrequency>
	1	</sy:updateFrequency>
	

<image>
	<url>https://www.yuanzhezixun.com/wp-content/uploads/2021/10/cropped-shcrilogo-c-45x45.jpg</url>
	<title>度拉糖肽售价 &#8211; 元哲咨询</title>
	<link>https://www.yuanzhezixun.com</link>
	<width>32</width>
	<height>32</height>
</image> 
	<item>
		<title>2021-2025年中国度拉糖肽市场研究报告(2020年销售额增长16倍)</title>
		<link>https://www.yuanzhezixun.com/report-on-chinas-dulaglutide-market/</link>
		
		<dc:creator><![CDATA[Timlee]]></dc:creator>
		<pubDate>Thu, 06 May 2021 09:20:55 +0000</pubDate>
				<category><![CDATA[医/药/保健]]></category>
		<category><![CDATA[报告速递]]></category>
		<category><![CDATA[行业资讯]]></category>
		<category><![CDATA[Eli Lilly]]></category>
		<category><![CDATA[GLP-1受体激动剂]]></category>
		<category><![CDATA[度拉糖肽]]></category>
		<category><![CDATA[度拉糖肽主要生产企业]]></category>
		<category><![CDATA[度拉糖肽售价]]></category>
		<category><![CDATA[度拉糖肽审批信息]]></category>
		<category><![CDATA[度拉糖肽市场]]></category>
		<category><![CDATA[度拉糖肽市场分剂型]]></category>
		<category><![CDATA[度拉糖肽市场报告]]></category>
		<category><![CDATA[度拉糖肽市场规模]]></category>
		<category><![CDATA[度拉糖肽销售情况]]></category>
		<category><![CDATA[抗糖尿病药物]]></category>
		<category><![CDATA[礼来]]></category>
		<category><![CDATA[糖尿病]]></category>
		<guid isPermaLink="false">http://www.yuanzhezixun.com/?p=23904</guid>

					<description><![CDATA[CRI元哲的调研数据显示，度拉糖肽自2019年进入中国市场后，销售额快速增长，从2019年的不足100万元上升至2020年的1037万元，年增长率为大约1600%。<div class='yarpp yarpp-related yarpp-related-rss yarpp-related-none yarpp-template-list'>

没有相关文章
</div>
]]></description>
		
		
		
			</item>
	</channel>
</rss>
